Advertisement

Histamine release induced by basic peptides and proteins

  • Kenji Tasaka

Abstract

Histamine release from mast cells is elicited not only by immunological stimuli but also various substances (Uvnäs, 1974; Tasaka, 1986; Foreman, 1988; Akagi and Tasaka 1991). Among them, it is of importance to elucidate the mechanism of histamine release induced by biological substances, such as neuropeptides or proteins, in association with the pathogenesis of allergic reactions. In this chapter, the histamine release induced by substance P, histone and eosinophil major basic protein was investigated.

Keywords

Mast Cell Histamine Release Peritoneal Mast Cell Major Basic Protein Partial Amino Acid Sequence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akagi M. and Tasaka K (1991) Comparative study of the adverse effects of various radiographic contrast media, including ioversol, a new low-osmolarity medium: (I) Histamine release. Meth. Find. Exp. CUn. Phannacol., 13: 377–384Google Scholar
  2. Aoki I., Shindoh Y., Nishida T., Nakai S., Hong Y.-M., Mio M., Saito T. and Tasaka K (1991a) Sequencing and cloning of the cDNA of guinea pig eosinophil major basic protein. FEBS Lett., 279: 330–334PubMedCrossRefGoogle Scholar
  3. Aoki I., Shindoh Y., Nishida T., Nakai S., Hong Y.-M., Mio M., Saito T. and Tasaka K (1991b) Comparison of the amino acid and nucleotide sequences between human and guinea pig major basic proteins. FEBS Lett., 282: 56–60PubMedCrossRefGoogle Scholar
  4. Ayars G.H., Altman L.C., Gleich G.J., Loegering D.A. and Baker C.B. (1985) Eosinophiland eosinophil granule-mediated pneumocyte injury. J. Allergy CUn. Immunol., 76: 595–604CrossRefGoogle Scholar
  5. Barker RL., Gleich G.J. and Pease L.R. (1988) Acidic precursor revealed in human eosinophil granule major basic protein cDNA. J. Exp. Med., 168: 1493–1498PubMedCrossRefGoogle Scholar
  6. Barker RL., Loegering D.A., Ten RM., Hamann KJ., Pease L.R and Gleich G.J. (1989) Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. J. Immunol., 143: 952–955PubMedGoogle Scholar
  7. Boggs J.M., Moscarello M.A. and Papahadjopoulos D. (1982) Structural organization of myelin - Role of lipid-protein interactions determined in model systems. In ‘Lipid-Protein Interactions vol. 2’, (eds.) Jost P.C. and Griffith O.H., John Wiley & Sons, New York, pp. 1–51Google Scholar
  8. Chakravarty N. and Nielsen E.M. (1985) Calmodulin in mast cells and its role in histamine secretion. Agents Actions, 16: 122–125PubMedCrossRefGoogle Scholar
  9. Ennis M., Atkinson G. and Pearce F.L. (1980) Inhibition of histamine release induced by compound 48/80 and peptide 401 in the presence and absence of calcium. Implication for the mode of action of anti-allergic compounds. Agents Actions, 10: 222–228PubMedCrossRefGoogle Scholar
  10. Fechter M., Egger D., Auer H. and Popper H. (1986) Experimental eosinophilia and inflammation - The effect of various inflammatory mediators and chemoattractants. Exp. Patlwl., 29: 153–158CrossRefGoogle Scholar
  11. Fewtrell C.M.S., Foreman J.C., Jordan C.C., Oehme P., Renner H. and Stewart J.M. (1982) The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J. Physiol., 330: 393–411PubMedGoogle Scholar
  12. Foreman J.C. (1988) The skin as an organ for the study of the pharmacology of neuropeptides. Skin Pharmacol., 1: 77–83PubMedCrossRefGoogle Scholar
  13. Foreman J. and Jordan C. (1983) Histamine release and vascular changes induced by neuropeptides. Agents Actions, 13: 105–116PubMedCrossRefGoogle Scholar
  14. Foreman J.C., Jordan C.C., Oehme P. and Renner H. (1983) Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J. Physiol., 335: 449–465PubMedGoogle Scholar
  15. Gleich G.J., Loegering D.A., Kueppers F.H., Bajaj S.P. and Mann K.G. (1974) Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J. Exp. Med., 140: 313–332PubMedCrossRefGoogle Scholar
  16. Gleich G.J., Loegering D.A., Mann K.G. and Maldonado J.E. (1976) Comparative properties of the Charcot Leyden crystal protein and the major basic protein from human eosinophils. J. Clin. Invest., 57: 633–640PubMedCrossRefGoogle Scholar
  17. Gleich G.J., Flavahan N.A., Fujisawa T. and Vanhoutte P.M. (1988) The eosinophil as a mediator of damage to respiratory epithelium: A model for bronchial hyperreactivity. J. AUergy C/in. Immunol., 81: 776–781CrossRefGoogle Scholar
  18. Gleich G.J., Ottesen E.A., Leiferman K.M. and Ackerman S.J. (1989) Eosinophils and human disease. Int. Arch. AUergy AppL Immunol., 88: 59–62CrossRefGoogle Scholar
  19. Higashijima T., Wakamatsu K., Wakamatsu M., Fujino M., Nakajima T. and Miyazawa T. (1983) Conformational change of mastoparan from wasp venom on binding with phospholipid membrane. FEBS Lett., 152: 227–230PubMedCrossRefGoogle Scholar
  20. Higashijima T., Burnier J. and Ross E.M. (1990) Regulation of Gi and Go by mastoparan, related amphiphilic peptides, and hydrophobic amines. J. BioL Chem., 265: 14176–14186PubMedGoogle Scholar
  21. Holzer-Petsche U., Schimek E., Amann R. and Lembeck F. (1985) In vivo and in vitro actions of mammalian tachykinins. Naunyn-Schmied. Arch. Pharmacol., 330: 130–135CrossRefGoogle Scholar
  22. Izushi K. and Tasaka K. (1989) Histamine release from, β-escin-permeabilized rat peritoneal mast cells and its inhibition by intracellular Ca2+ blockers, calmodulin inhibitors and cAMP. Immunopharmacology, 18: 177–186PubMedCrossRefGoogle Scholar
  23. Mercum J.M., Dedman J.R., Brinkley B.R. and Means A.R. (1978) Control of microtubule assembly-disassembly by calcium-dependent regulator protein. Proc. NatL Acad. Sci. USA, 75: 3771–3775CrossRefGoogle Scholar
  24. Mio M. and Tasaka K. (1989) Microfilament-associated, local degranulation of rat peritoneal mast cells. Int. Arch. AUergy AppL Immunol., 88: 369–371CrossRefGoogle Scholar
  25. Mio M., Izushi K. and Tasaka K. (1991) Substance P-induced histamine release from rat peritoneal mast cells and its inhibition by antiallergic agents and calmodulin inhibitors. Immunopharmacowgy, 22: 59–66CrossRefGoogle Scholar
  26. Mousli M., Bronner C., Landry Y., Bockaert J. and Rouot B. (1990) Direct activation of GTP-binding regulatory proteins (G-proteins) by substance P and compound 48/80. FEBS Lett., 259: 260–262PubMedCrossRefGoogle Scholar
  27. Pearce F.L., Kassessinoff T.A. and Liu W.L. (1989) Characteristics of histamine secretion induced by neuropeptides: implications for the relevance of peptide-mast cell interactions in allergy and inflammation. Int. Arch. Allergy AppL Immunol., 88: 129–131PubMedCrossRefGoogle Scholar
  28. Pincus S.H., DiNapoli A.-N. and Schooley W.R. (1982) Superoxide production by eosinophils: Activation by histamine. J. Invest. Dermatol., 79: 53–57PubMedCrossRefGoogle Scholar
  29. Piotrowski W. and Foreman J.C. (1985) On the action of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. NaunynSchmied. Arch. Pharmacol., 331: 364–368CrossRefGoogle Scholar
  30. Repke H. and Bienert M. (1988) Structural requirements for mast cell triggering by substance P-like peptides. Agents Actions, 23: 207–210PubMedCrossRefGoogle Scholar
  31. Repke H., Piotrowski W., Bienert M. and Foreman J.C. (1987) Histamine release induced by Arg-Pro-Lys-Pro-(CH2)11CH3 from rat peritoneal mast cells. J. PharmacoL Exp. Ther., 243: 317–321PubMedGoogle Scholar
  32. Sagi-Eisenberg R., Foreman J.C. and Shelly R. (1985) Histamine release induced by histone and phorbol ester from rat peritoneal mast cells. Eur. J. Pharmacol., 113: 11–17PubMedCrossRefGoogle Scholar
  33. Shibata H., Mio M. and Tasaka K (1985) Analysis of the mechanism of histamine release induced by substance P. Biochim. Biophys. Acta, 846: 1–7PubMedCrossRefGoogle Scholar
  34. Tasaka K (1986) Anti-allergic drugs. Drugs Today, 22: 101–133Google Scholar
  35. Tasaka K and Mio M. (1989) Microfilament-associated degranulation of sensitized guinea-pig lung mast cells. Agents ActiQns, 27: 79–82CrossRefGoogle Scholar
  36. Tasaka K, Sugiyama K, Komoto S. and Yamasaki H. (1970) Repeated local degranulation of isolated rat mast cell by microelectrophoresis of basic histamine releasers. Proc. Japan. Acad., 46: 311–316Google Scholar
  37. Tasaka K, Mio M., Okamoto M. (1986) Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs. Ann. Allergy, 56: 464–469PubMedGoogle Scholar
  38. Tasaka K, Akagi M., Mio M., Miyoshi M. and Nakaya N. (1987) Inhibitory effects of oxatomide on intracellular Ca mobilization, Ca uptake and histamine release, using rat peritoneal mast cells. Int. Arch. Allergy AppL Immunol., 83: 348–353PubMedCrossRefGoogle Scholar
  39. Tasaka K, Akagi M., Miyoshi K and Mio M. (1988) Role of microfilaments in the exocytosis of rat peritoneal mast cells. Int. Archs. Allergy AppL Immunol., 87: 213–221CrossRefGoogle Scholar
  40. Tasaka K, Mio M., Akagi M. and Saito T. (1990) Histamine release induced by histone and related morphological changes in mast cells. Agents Actions, 30: 114–117PubMedCrossRefGoogle Scholar
  41. Tasaka K, Mio M., Fujisawa K and Aoki I. (1991) Role of microtubules on Ca2+ release from the endoplasmic reticulum and associated histamine release from rat peritoneal mast cells. Biochem. Pharmacol., 41: 1031–1037PubMedCrossRefGoogle Scholar
  42. Tasaka K, Mio M., Aoki I. and Saito T. (1992a) Guinea pig eosinophil major basic protein (GMBP) as a potent histamine releaser. (I) Histamine releasing activity of GMBP and its chemical structure. Agenty Actions, 36/Spec. Iss.: C242–C245CrossRefGoogle Scholar
  43. Tasaka K, Mio M., Nakai S. and Aoki I. (1992b) Guinea pig eosinophil major basic protein as a potent histamine releaser. (II) Structure-activity relationships of GMBP1 and GMBP2. Agenty Actions, 36/Spec. Iss.: C246–C249CrossRefGoogle Scholar
  44. Uvniis B. (1974) Histamine storage and release. Fed. Proc., 33: 2172–2176Google Scholar
  45. Wardlaw A.J., Moqbel R., Cromwell O. and Kay A.B. (1986) Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J. Clin. Invest., 78: 1701–1706PubMedCrossRefGoogle Scholar
  46. Watson S.P. (1984) Are the proposed substance P receptor sub-types, substance P receptors? Life Sci., 35: 797–808PubMedCrossRefGoogle Scholar
  47. Yazawa M., Yagi K. and Sobue K. (1987) Isolation and characterization of a cahnodulin binding fragment of chicken gizzard caldesmon. J. Biochem., 102: 1065–1073PubMedGoogle Scholar
  48. Yoshii N., Mio M. and Tasaka K. (1988) Ca uptake and Ca releasing properties of the endoplasmic reticulum in rat peritoneal mast cells. Immurwpharmacology, 16: 107–113CrossRefGoogle Scholar
  49. Zheutlin L.M., Ackerman S.J., Gleich G.J. and Thomas L.L. (1984) Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J. Immurwl., 133: 2180–2185Google Scholar

Copyright information

© Springer-Verlag Tokyo 1994

Authors and Affiliations

  • Kenji Tasaka
    • 1
  1. 1.The Department of Pharmacology in the Faculty of Pharmaceutical SciencesOkayama UniversityOkayamaJapan

Personalised recommendations